Policy | April 16, 2026
India chairs first BRICS Health Working Group meet
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
The approach, which could significantly reduce the number of rats used in certain dose-range finding studies
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
His professional background also includes key experience at Matrix Labs and Sun Pharma
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Subscribe To Our Newsletter & Stay Updated
